US managed care insurers were trading down this week ahead of earnings season as the release of Medicare ratings and federal tax credit uncertainty appeared to weigh on stock prices. The S&P 500 and S&P Insurance Index similarly declined, falling 1.29% and 7.03%.
A U.S. judge on Tuesday rejected Humana's bid to challenge the Centers for Medicare & Medicaid Services' 2025 ratings for its Medicare Advantage programs, which could cost the company millions in bonus payments from the government.
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced its ambition to become a national leader in addressing seniors' emotional health. More than one in four seniors (29%) report being socially isolated, increasing their risk of dementia (by 50%) and self-harm. The Foundation's 2025 program and research g...
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance...
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Humana between July 27, 2022, to January 24, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-...
Shares of a major health insurer notched strong gains after the company offered a peek into the quality ratings of its plans. Meanwhile, reports of a government memo raising security concerns weighed on the stock of an AI software darling.
Humana said on Thursday it has about 20% of its members currently enrolled in Medicare Advantage plans rated 4 stars and above for 2026, based on preliminary data.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.